These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8459056)

  • 41. Argatroban and Bivalirudin for Perioperative Anticoagulation in Cardiac Surgery.
    Koster A; Faraoni D; Levy JH
    Anesthesiology; 2018 Feb; 128(2):390-400. PubMed ID: 29206646
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of argatroban, a selective thrombin inhibitor, on animal models of cerebral thrombosis.
    Tamao Y; Kikumoto R
    Semin Thromb Hemost; 1997; 23(6):523-30. PubMed ID: 9469624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model.
    Imura Y; Stassen JM; Collen D
    J Pharmacol Exp Ther; 1992 Jun; 261(3):895-8. PubMed ID: 1602394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Argatroban, a thrombin inhibitor, decreased mortality after 10 min of forebrain ischemia in the gerbil.
    Mima T; Jin YJ; Hirayama T; Mostafa MG; Mori K
    Neurosci Lett; 2000 Jan; 279(2):93-6. PubMed ID: 10674629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor.
    Hursting MJ; Alford KL; Becker JC; Brooks RL; Joffrion JL; Knappenberger GD; Kogan PW; Kogan TP; McKinney AA; Schwarz RP
    Semin Thromb Hemost; 1997; 23(6):503-16. PubMed ID: 9469622
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Argatroban.
    McKeage K; Plosker GL
    Drugs; 2001; 61(4):515-22; discussion 523-4. PubMed ID: 11324681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors.
    Van Cott EM; Roberts AJ; Dager WE
    Semin Thromb Hemost; 2017 Apr; 43(3):270-276. PubMed ID: 28052306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Meta-analysis of the role of Argatroban in renal replacement therapy].
    Cao FF; Zhang HT; Feng X; Jiao RN
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Dec; 35(6):667-71. PubMed ID: 24382247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical trials of direct thrombin inhibitors during invasive procedures.
    Hermann JP; Kutryk MJ; Serruys PW
    Thromb Haemost; 1997 Jul; 78(1):367-76. PubMed ID: 9198181
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of antithrombin on Binswanger's disease with antiphospholipid antibody syndrome.
    Akiguchi I; Tomimoto H; Kinoshita M; Wakita H; Osaki A; Nishimura M; Kimura J
    Neurology; 1999 Jan; 52(2):398-401. PubMed ID: 9932966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Practical issues in the development of argatroban: a perspective.
    Fareed J; Hoppensteadt D; Iqbal O; Tobu M; Lewis BE
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 3():56-65. PubMed ID: 12811013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The combination of thrombin inhibitor and thromboxane synthase inhibitor on experimental thrombosis and bleeding.
    Kawai H; Tamao Y
    Thromb Res; 1995 Dec; 80(5):429-34. PubMed ID: 8588204
    [No Abstract]   [Full Text] [Related]  

  • 53. [A case of Fournier's gangrene with healing accelerated by argatroban].
    Soda T; Ogura K
    Hinyokika Kiyo; 1996 Dec; 42(12):981-2. PubMed ID: 9013237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Argatroban, an attractive anticoagulant, for left heart bypass with centrifugal pump for repair of traumatic aortic rupture.
    Kawada T; Okada Y; Hoson M; Endo S; Yokoyama M; Kitanaka Y; Kimura K; Abe H; Yamate N
    Jpn J Thorac Cardiovasc Surg; 1999 Mar; 47(3):104-9. PubMed ID: 10226408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heparin-induced thrombocytopenia with aortoiliac thrombosis treated with argatroban.
    Alarcón Pérez L; Rodríguez Huerta AM; Duque González P
    Med Clin (Barc); 2017 Mar; 148(6):286-287. PubMed ID: 28131516
    [No Abstract]   [Full Text] [Related]  

  • 56. [Argatroban: pharmacological properties and anaesthesiological aspects].
    Kleinschmidt S; Stephan B; Pindur G; Bauer C
    Anaesthesist; 2006 Apr; 55(4):443-50. PubMed ID: 16389543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study.
    Bath PM
    Stroke; 2012 Mar; 43(3):623-4. PubMed ID: 22223236
    [No Abstract]   [Full Text] [Related]  

  • 58. In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activator.
    Jang IK; Gold HK; Leinbach RC; Fallon JT; Collen D
    Circ Res; 1990 Dec; 67(6):1552-61. PubMed ID: 2123135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct thrombin inhibitors in cardiovascular medicine.
    Lefkovits J; Topol EJ
    Circulation; 1994 Sep; 90(3):1522-36. PubMed ID: 8087958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Substitution of antithrombin III by synthetic thrombin inhibitors].
    Hauptmann J; Brüggener E; Müller H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):550-5. PubMed ID: 6083925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.